NEW YORK (GenomeWeb) – While it didn't make as big a splash as last year, the 2016 edition of the Genome Engineering: The CRISPR/Cas Revolution meeting showed the extent to which the technology is becoming a basic research tool.

Last week, scientists from around the world gathered at Cold Spring Harbor Laboratory to share advances in CRISPR and its applications in several fields, including — but certainly not limited to — cancer biology, gene therapy, ag-bio, and DNA repair pathways.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.